Ignite Creation Date:
2025-12-25 @ 12:17 AM
Ignite Modification Date:
2026-01-02 @ 6:53 PM
Study NCT ID:
NCT06574958
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-28
First Post:
2024-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of CD38\CS1 Chimeric Antigen Receptor T Cells in the Treatment of Refractory/Recurrent Multiple Myeloma
Sponsor:
The Second Hospital of Shandong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-13
First Submit QC Date:
None
Study First Post Date:
2024-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-26
Last Update Post Date:
2024-08-28
Last Update Post Date Type:
ACTUAL